FASN and atherosclerosis: Accumulating evidence of estrogen-associated physiology including suppression of triacylglycerol (TG) storage in fat and liver tissues [33]–[36], reduction of expression and enzymatic activity of FASN [37], and preventive effect for foam cell formation and the development of atherosclerosis [38]–[41], which are all reminiscent of AIM function [20], [29], [30], [42], [43].